Showing results (1-10 of 136) with videos related to
Sort By:
Pageof 14
Biofactors (Oxford, England)|August 12, 1998
Enhanced oxidative damage in cystic fibrosis patientsC Domínguez, S Gartner, S Liñán, et al.Journal of Computer Assisted Tomography|July 24, 1998
Spectrum of manifestations of Swyer-James-MacLeod syndromeJ Lucaya, S Gartner, P García-Peña, et al.European Journal of Pediatrics|February 9, 2000
DNase use in the daily care of cystic fibrosis: who benefits from it and to what extent? Results of a cohort study of 199 patients in 13 centres. DNase National Study GroupN Cobos, I Danés, S Gartner, et al.Anales Espanoles De Pediatria|November 6, 1998
[Exhaled and nasal nitric oxide in normal and asthmatic children]N Cobos Barroso, C Reverté Bover, S Gartner, et al.Anales De Pediatria (Barcelona, Spain : 2003)|October 8, 2004
[Comparative efficacy of oral deflazacort versus oral prednisolone in children with moderate acute asthma]S Gartner, N Cobos, E G Pérez-Yarza, et al.Thorax|March 7, 2006
Upregulation of COX-1 and COX-2 in nasal polyps in cystic fibrosisJ Roca-Ferrer, L Pujols, S Gartner, et al.Anales Espanoles De Pediatria|June 1, 1992
[Tissue damage and immunological responses in acute bronchopulmonary infections]N Cobos BarrosoClinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 18, 2005
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patientsR Cantón, N Cobos, J de Gracia, et al.Science (New York, N.Y.)|September 11, 1970
Sea-floor spreading, carbonate dissolution level, and the nature of horizon aS GartnerPageof 14